Pharma Biotools

The Q2 2026 Pharma Biotools Report provides an analysis of recent VC activity and includes a link to our proprietary market map of leading VC-backed companies in the space.

The Q1 2026 Pharma Biotools VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

The Q4 2025 Pharma Biotools VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

The Q3 2025 Pharma Biotools VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

Founders say they’re workshopping their edge over conventional LLMs for drug development purposes.

The Q2 2025 Pharma Biotools VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

The Q1 2025 Pharma Biotools VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.

This analysis provides investors and fund managers with a data-driven view of biotech VC performance and structural trends.

The 2025 Pharma Biotools VC Ecosystem Overview includes market maps of VC-backed companies; business model descriptions; and an overview of key deals, exits, and incumbents within biopharma tools.

The Q4 2024 Pharma Biotools VC Trends report provides an analysis of recent VC activity and includes a market map of leading VC-backed companies in the space.